Leading pomegranate researcher Dr. Navindra Seeram to speak on pomegranate bioavailability at Supplyside West

Las Vegas, NV—After plenty of attention this past year on pomegranate and tea research, new studies delve into the in vivo bioavailability of their polyphenols, offering new insight into how they are absorbed and metabolized.



Dr. Navindra Seeram, Assistant Director of the University of California Los Angeles (UCLA) Center for Human Nutrition, will present “Are Polyphenols from Pomegranates, Strawberries and Tea Bioavailable in Human and Animal Blood and Tissues?” on Friday, November 11, at 10 am during the Educational Sessions of Supplyside West, Las Vegas.



The research, finding that health benefits of polyphenols from various foods and dietary supplements may be due to a combination of the biological activities of both their intact and metabolite forms, is the latest on recent findings of the health benefits of pomegranate.



Dr. Seeram’s last published paper on pomegranate, in the May issue of the Journal of Nutritional Biochemistry, found that a pomegranate concentrate normalized to punicalagins—the main polyphenols responsible for pomegranate juice’s antioxidant activity—displayed more potent antioxidant effects in vitro than any one compound isolated from pomegranate, suggesting that synergistic effects could also be displayed in the body as well.



With long-term clinical research plans scheduled for pomegranate extracts such as PomElla®, made by Geni Herbs, hard evidence of pomegranate’s in vivo health benefits continues to grow.

Be sure to visit Geni Herbs at booth# 6054 to find out more about PomElla, the science-backed, natural-spectrum pomegranate ingredient and first to be standardized to punicalagins. Only there can you get the latest GH research report, find out the “PomElla Difference”, and be the first to sample an all-new beverage application of PomElla.